These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21109437)

  • 1. Validating the MSKCC nomogram and a clinical decision rule in the prediction of non-sentinel node metastases in a Portuguese population of breast cancer patients.
    Fougo JL; Senra FS; Araújo C; Dias T; Afonso M; Leal C; Dinis-Ribeiro M
    Breast; 2011 Apr; 20(2):134-40. PubMed ID: 21109437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
    van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
    Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
    D'Eredità G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
    Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study.
    Gur AS; Unal B; Ozbek U; Ozmen V; Aydogan F; Gokgoz S; Gulluoglu BM; Aksaz E; Ozbas S; Baskan S; Koyuncu A; Soran A;
    Eur J Surg Oncol; 2010 Jan; 36(1):30-5. PubMed ID: 19535217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
    Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
    Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population.
    Klar M; Jochmann A; Foeldi M; Stumpf M; Gitsch G; Stickeler E; Watermann D
    Breast Cancer Res Treat; 2008 Dec; 112(3):523-31. PubMed ID: 18172758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node.
    Perhavec A; Perme MP; Hocevar M; Besić N; Zgajnar J
    Breast Cancer Res Treat; 2010 Jan; 119(2):357-66. PubMed ID: 19787449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer population.
    Klar M; Foeldi M; Markert S; Gitsch G; Stickeler E; Watermann D
    Ann Surg Oncol; 2009 May; 16(5):1136-42. PubMed ID: 19259742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of Memorial Sloan-Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer.
    van den Hoven I; Kuijt GP; Voogd AC; van Beek MW; Roumen RM
    Br J Surg; 2010 Nov; 97(11):1653-8. PubMed ID: 20641050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating a predictive model for presence of additional disease in the non-sentinel lymph nodes of a woman with sentinel node positive breast cancer.
    Van Zee KJ; Kattan MW
    Ann Surg Oncol; 2007 Aug; 14(8):2177-8. PubMed ID: 17508249
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of the Memorial Sloan-Kettering Cancer Center nomogram to predict sentinel lymph node metastases in a Dutch breast cancer population.
    van la Parra RF; Francissen CM; Peer PG; Ernst MF; de Roos WK; Van Zee KJ; Bosscha K
    Eur J Cancer; 2013 Feb; 49(3):564-71. PubMed ID: 22975214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
    Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
    J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of nomograms to predict the risk of non-sentinels lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement.
    Hidar S; Harrabi I; Benregaya L; Fatnassi R; Khelifi A; Benabdelkader A; Trabelsi A; Bouaouina N; Ben Ahmed S; Bibi M; Khaïri H
    Breast; 2011 Feb; 20(1):26-30. PubMed ID: 20729084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a breast cancer nomogram for predicting the likelihood of additional nodal metastases in patients with a positive sentinel node biopsy.
    Scomersi S; Torelli L; Zanconati F; Tonutti M; Dore F; Bortul M
    Ann Ital Chir; 2012; 83(6):461-8. PubMed ID: 23110902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram.
    Cripe MH; Beran LC; Liang WC; Sickle-Santanello BJ
    Am J Surg; 2006 Oct; 192(4):484-7. PubMed ID: 16978955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system.
    Unal B; Gur AS; Kayiran O; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Clin Pract; 2008 Nov; 62(11):1785-91. PubMed ID: 19143863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.
    Lambert LA; Ayers GD; Hwang RF; Hunt KK; Ross MI; Kuerer HM; Singletary SE; Babiera GV; Ames FC; Feig B; Lucci A; Krishnamurthy S; Meric-Bernstam F
    Ann Surg Oncol; 2006 Mar; 13(3):310-20. PubMed ID: 16463073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement: evaluation of two scoring systems.
    Sanjuán A; Escaramís G; Vidal-Sicart S; Illa M; Zanón G; Pahisa J; Rubí S; Velasco M; Santamaría G; Farrús B; Muñoz M; García Y; Fernández PL; Pons F
    Breast J; 2010; 16(2):134-40. PubMed ID: 20136644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.